316 related articles for article (PubMed ID: 30257123)
1. Childhood-onset craniopharyngioma: latest insights into pathology, diagnostics, treatment, and follow-up.
Bogusz A; Müller HL
Expert Rev Neurother; 2018 Oct; 18(10):793-806. PubMed ID: 30257123
[TBL] [Abstract][Full Text] [Related]
2. New outlook on the diagnosis, treatment and follow-up of childhood-onset craniopharyngioma.
Müller HL; Merchant TE; Puget S; Martinez-Barbera JP
Nat Rev Endocrinol; 2017 May; 13(5):299-312. PubMed ID: 28155902
[TBL] [Abstract][Full Text] [Related]
3. Risk-adapted, long-term management in childhood-onset craniopharyngioma.
Müller HL
Pituitary; 2017 Apr; 20(2):267-281. PubMed ID: 27604996
[TBL] [Abstract][Full Text] [Related]
4. Childhood craniopharyngioma - changes of treatment strategies in the trials KRANIOPHARYNGEOM 2000/2007.
Hoffmann A; Warmth-Metz M; Gebhardt U; Pietsch T; Pohl F; Kortmann RD; Calaminus G; Müller HL
Klin Padiatr; 2014 May; 226(3):161-8. PubMed ID: 24819386
[TBL] [Abstract][Full Text] [Related]
5. Childhood-onset Craniopharyngioma.
Otte A; Müller HL
J Clin Endocrinol Metab; 2021 Sep; 106(10):e3820-e3836. PubMed ID: 34086900
[TBL] [Abstract][Full Text] [Related]
6. Craniopharyngioma: long-term consequences of a chronic disease.
Müller HL
Expert Rev Neurother; 2015; 15(11):1241-4. PubMed ID: 26523617
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis, treatment, clinical course, and prognosis of childhood-onset craniopharyngioma patients.
Müller HL
Minerva Endocrinol; 2017 Dec; 42(4):356-375. PubMed ID: 28181780
[TBL] [Abstract][Full Text] [Related]
8. Risk-adapted treatment and follow-up management in childhood-onset craniopharyngioma.
Müller HL
Expert Rev Neurother; 2016 May; 16(5):535-48. PubMed ID: 26982163
[TBL] [Abstract][Full Text] [Related]
9. Advances in the management of craniopharyngioma in children and adults.
Jensterle M; Jazbinsek S; Bosnjak R; Popovic M; Zaletel LZ; Vesnaver TV; Kotnik BF; Kotnik P
Radiol Oncol; 2019 Oct; 53(4):388-396. PubMed ID: 31652121
[TBL] [Abstract][Full Text] [Related]
10. Craniopharyngioma.
Müller HL
Endocr Rev; 2014 Jun; 35(3):513-43. PubMed ID: 24467716
[TBL] [Abstract][Full Text] [Related]
11. The Diagnosis and Treatment of Craniopharyngioma.
Müller HL
Neuroendocrinology; 2020; 110(9-10):753-766. PubMed ID: 31678973
[TBL] [Abstract][Full Text] [Related]
12. Analyses of treatment variables for patients with childhood craniopharyngioma--results of the multicenter prospective trial KRANIOPHARYNGEOM 2000 after three years of follow-up.
Müller HL; Gebhardt U; Schröder S; Pohl F; Kortmann RD; Faldum A; Zwiener I; Warmuth-Metz M; Pietsch T; Calaminus G; Kolb R; Wiegand C; Sörensen N;
Horm Res Paediatr; 2010; 73(3):175-80. PubMed ID: 20197669
[TBL] [Abstract][Full Text] [Related]
13. Magnetic resonance imaging as predictor of functional outcome in craniopharyngiomas.
Mortini P; Gagliardi F; Bailo M; Spina A; Parlangeli A; Falini A; Losa M
Endocrine; 2016 Jan; 51(1):148-62. PubMed ID: 26179178
[TBL] [Abstract][Full Text] [Related]
14. Relapse pattern after complete resection and early progression after incomplete resection of childhood craniopharyngioma.
Müller HL; Gebhardt U; Pohl F; Flentje M; Emser A; Warmuth-Metz M; Kolb R; Calaminus G; Sörensen N
Klin Padiatr; 2006; 218(6):315-20. PubMed ID: 17080333
[TBL] [Abstract][Full Text] [Related]
15. Surgical Outcomes of Endoscopic Endonasal Skull Base Surgery of Craniopharyngiomas Evaluated According to the Degree of Hypothalamic Extension.
Yano S; Hide T; Shinojima N
World Neurosurg; 2017 Apr; 100():288-296. PubMed ID: 28089805
[TBL] [Abstract][Full Text] [Related]
16. Craniopharyngioma and hypothalamic injury: latest insights into consequent eating disorders and obesity.
Müller HL
Curr Opin Endocrinol Diabetes Obes; 2016 Feb; 23(1):81-9. PubMed ID: 26574645
[TBL] [Abstract][Full Text] [Related]
17. Consequences of craniopharyngioma surgery in children.
Müller HL
J Clin Endocrinol Metab; 2011 Jul; 96(7):1981-91. PubMed ID: 21508127
[TBL] [Abstract][Full Text] [Related]
18. Long-term outcomes of multidisciplinary treatment combining surgery and stereotactic radiotherapy with Novalis for craniopharyngioma.
Shinojima N; Yano S; Uchida D; Mizukami N; Mabe H; Kawashima J; Igata M; Kondo T; Uetani H; Yamamoto T; Uekawa K; Hide T; Mikami Y; Hirai T; Mukasa A
J Clin Neurosci; 2024 Feb; 120():138-146. PubMed ID: 38244528
[TBL] [Abstract][Full Text] [Related]
19. Clinical outcome in children with craniopharyngioma treated with primary surgery and radiotherapy deferred until relapse.
Kalapurakal JA; Goldman S; Hsieh YC; Tomita T; Marymont MH
Med Pediatr Oncol; 2003 Apr; 40(4):214-8. PubMed ID: 12555247
[TBL] [Abstract][Full Text] [Related]
20. Neuroendocrine Disorders in Pediatric Craniopharyngioma Patients.
Daubenbüchel AM; Müller HL
J Clin Med; 2015 Mar; 4(3):389-413. PubMed ID: 26239246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
